NORTH WALES, Pa. — Teva Women’s Health, the U.S subsidiary of Teva Pharmaceuticals, announced on Wednesday that the emergency contraceptive Plan B One-Step (levonorgestrel) tablet 1.5 mg is now widely available at retail with no age or point-of-sale restrictions. Plan B One-Step marks the first emergency contraceptive to be available for OTC sale to all consumers.
“Since the U.S. Food and Drug Administration approved Plan B One-Step with no age or point-of-sale restrictions on June 20, we have worked tirelessly to bring the product to market for all consumers as soon as possible,” stated Martin Berndt, VP and GM, U.S. Brand Pharmaceuticals for Teva Women’s Health. “The availability of Plan B One-Step in the aisles of retailers nationwide ensures improved access to a product that has been clinically evaluated and is a safe and effective back-up birth control method for women of all reproductive ages.”
Teva stressed its commitment to ensuring Plan B One-Step is available to all women who need it. As such, the price of Plan B One-Step to wholesale and retail outlets will remain unchanged as it transitions to OTC. In addition to now being available in aisle, Plan B One-Step also will continue to be sold to hospitals and health clinics at a subsidized price for women who may not otherwise be able to afford it.
“As a leader in women’s health, Teva is committed to supporting and empowering women by providing access to Plan B One-Step when they need it,” added Jill DeSimone, SVP and GM of Teva Global Women's Health. “Teva remains committed to ongoing consumer education on Plan B One-Step and will continue to work closely on education initiatives in partnership with healthcare professionals.”